(Q49613130)

21 February 2018

title

Pharmacological Therapy after Acute Cervical Spinal Cord Injury. (English)

1 reference

21 February 2018

author name string

M N Hadley

1

1 reference

21 February 2018

B C Walters

2

1 reference

21 February 2018

P A Grabb

3

1 reference

21 February 2018

N M Oyesiku

4

1 reference

21 February 2018

G J Przybylski

5

1 reference

21 February 2018

D K Resnick

6

1 reference

21 February 2018

T C Ryken

7

1 reference

21 February 2018

language of work or name

English

0 references

publication date

1 March 2002

1 reference

21 February 2018

published in

Neurosurgery

1 reference

21 February 2018

volume

50

1 reference

21 February 2018

issue

suppl_3

1 reference

21 February 2018

page(s)

S63-S72

1 reference

21 February 2018

Pathogenesis and pharmacological strategies for mitigating secondary damage in acute spinal cord injury

cites work

1 reference

https://api.crossref.org/works/10.1097%2F00006123-200203001-00013

Clinical measurement, statistical analysis, and risk-benefit: controversies from trials of spinal injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00006123-200203001-00013

Methylprednisolone or naloxone treatment after acute spinal cord injury: 1-year follow-up data. Results of the second National Acute Spinal Cord Injury Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00006123-200203001-00013

A Randomized, Controlled Trial of Methylprednisolone or Naloxone in the Treatment of Acute Spinal-Cord Injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00006123-200203001-00013

Administration of methylprednisolone for 24 or 48 hours or tirilazad mesylate for 48 hours in the treatment of acute spinal cord injury. Results of the Third National Acute Spinal Cord Injury Randomized Controlled Trial. National Acute Spinal Cord I

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00006123-200203001-00013

Methylprednisolone or tirilazad mesylate administration after acute spinal cord injury: 1-year follow up. Results of the third National Acute Spinal Cord Injury randomized controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00006123-200203001-00013

Spinal cord injury. Role of steroid therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00006123-200203001-00013

The two-edged sword of large-dose steroids for spinal cord trauma

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00006123-200203001-00013

Recovery of motor function after spinal-cord injury--a randomized, placebo-controlled trial with GM-1 ganglioside

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00006123-200203001-00013

Consequences of high-dose steroid therapy for acute spinal cord injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00006123-200203001-00013

GM-1 Ganglioside for Spinal-Cord Injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00006123-200203001-00013

Early complications of high-dose methylprednisolone sodium succinate treatment in the follow-up of acute cervical spinal cord injury.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00006123-200203001-00013

Steroids and spinal cord injury: revisiting the NASCIS 2 and NASCIS 3 trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00006123-200203001-00013

Use of steroids for acute spinal cord injury must be reassessed

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00006123-200203001-00013

High dose methylprednisolone in the management of acute spinal cord injury - a systematic review from a clinical perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00006123-200203001-00013

Biology of neurological recovery and functional restoration after spinal cord injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00006123-200203001-00013

10.1097/00006123-200203001-00013

21 January 2018

Identifiers

DOI

1 reference

21 February 2018

12431289

1 reference

21 February 2018